M
IMEPro
G57.50 Neurological Parent Code
Updated March 2026

Tarsal tunnel syndrome, unspecified lower limb

ICD-10 Code: G57.50 · Body Part: Ankle/Foot

QME Evaluation Process

Tinel's sign at medial malleolus, sensory testing of plantar surface, EMG/NCS for tibial nerve entrapment. LE impairment per peripheral nerve tables.

Typical Impairment Rating

3-10% LE (1-4% WPI)

AMA Guides Edition

5th Edition

Common Treatments

+ Orthotics
+ Tarsal tunnel release surgery
+ Physical therapy

Related Conditions

Body Part Guide

Ankle/Foot Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Tarsal tunnel syndrome, unspecified lower limb

Find a QME Specialist

Browse QME-certified physicians who evaluate tarsal tunnel syndrome, unspecified lower limb and related ankle/foot conditions in California.

Browse Physical Medicine & Rehabilitation Physicians →

Frequently Asked Questions

What is Tarsal tunnel syndrome, unspecified lower limb (G57.50)?

Tarsal tunnel syndrome, unspecified lower limb is an ICD-10 diagnosis code (G57.50) classified under Neurological conditions. It affects the Ankle/Foot and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is G57.50 rated for impairment?

The typical whole person impairment (WPI) range for Tarsal tunnel syndrome, unspecified lower limb is 3-10% LE (1-4% WPI). The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for G57.50?

Tinel's sign at medial malleolus, sensory testing of plantar surface, EMG/NCS for tibial nerve entrapment. LE impairment per peripheral nerve tables.

What treatments are common for Tarsal tunnel syndrome, unspecified lower limb?

Common treatments for Tarsal tunnel syndrome, unspecified lower limb include Orthotics, Tarsal tunnel release surgery, Physical therapy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.